🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSemaglutide and MASH — March 2026 Page 3

Semaglutide and MASH — March 2026

sophie_paris Tue, Dec 17, 2024 at 7:15 PM 42 replies 2,138 viewsPage 3 of 9
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Dec 17, 2024 at 11:30 PM#11

+1 to HPLC_Greg. Especially the point about "PainCLE perspective but I think this ove..." — I have seen the same in my own experience with Semaglutide and MASH .

33 16Dr.LeslieOBGYN, MikeNYC_runner and 30 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Dec 17, 2024 at 11:47 PM#12

Want to share my personal experience related to Semaglutide and MASH March since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 288 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 10 months later: I am down 53 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The Semaglutide and MASH aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.

Last edited: Dec 18, 2024 at 12:47 AM
37 4andrew_nyc, Dr.EndoEP, GraceAZ_72 and 34 others
Reply Quote Save Share Report
CanadaChris
Member
234
890
Nov 2024
Toronto, CA
Dec 18, 2024 at 12:04 AM#13

newstart_MO — that is really helpful context on Semaglutide and MASH . Follow-up question: did you change anything about your diet at the same time?

I am in a similar situation (month 2) and trying to set realistic expectations.

1 7maya_sedona
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Dec 18, 2024 at 12:21 AM#14

To answer Dr.ReproEndo's question specifically:

From a clinical standpoint, Semaglutide and MASH March is well-supported by the literature.

The short answer: follow the standard titration protocol and reassess at 4-6 weeks.

The longer answer involves pharmacokinetic considerations around steady-state concentrations, which I am happy to elaborate on if helpful.

1 16Admin
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Dec 18, 2024 at 12:38 AM#15

Saving this for reference. Top-tier content.

8 10Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 5 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register